You have to wonder if Inmed has caught the attention of Dr.Frost of OPKO. Seems like a good match for what he looks for in a company:
OPKO Health (OPK) may be less well known than biotech behemoths like Amgen, Allergan or Gilead, but it has nevertheless progressed into a mighty achiever in developing significantly important drugs within just a few years as an upstart in the complex universe of biotechnology.
OPKO has achieved this success largely by being a smart acquirer of undiscovered an underpriced biotech assets, which has enabled the company to build a pipeline of important drugs and drug candidates.